Skip to content
  • Home
  • IOncology
  • Infectious Desease Frontier
  • IHepatology
  • Hematology Frontier
  • Conference topics
  • Experts Interviews
  • Informations
  • Live Broadcasting
  • Logout
MediaMedic

Connecting Medical Expertise through Media

  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
  • Home
  • IOncology
  • Infectious Disease Frontier
  • International Hepatology
  • Hematology Frontier
  • Conference topics
  • Experts’ Interviews
  • Informations
Headlines
2026 Pujiang Urological Oncology Academic Conference丨Professor Shudong Zhang: Surgical Treatment and Multidisciplinary Management of UTUC with Inferior Vena Cava Tumor Thrombus — From Precise Imaging Assessment to Robotic Minimally Invasive Thrombectomy and Comprehensive Care
2026.09.02
2026 Pujiang Urological Oncology Academic Conference丨Nan Liu: Precision Strategies for Robot-Assisted Partial Nephrectomy of Completely Endophytic Renal Tumors—from Preoperative 3D Planning to Intraoperative Localization and Nephron-Sparing Decision-Making
2026.09.02
The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders
2026.08.28
The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing
2026.08.28
The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology
2026.08.28
The 14th Lu Daopei Hematology Forum | Dongchu Wang: Unlocking the Predictive Value of Cytokines and Optimizing the Entire Treatment Pathway—Research and Prospects of CD7 CAR-T as a Bridge to Transplantation
2026.08.28
The 14th Lu Daopei Hematology Forum | Dr. Shu Yan: Stratified Prevention and Control, Comprehensive Management—Strategies for the Diagnosis and Treatment of Invasive Fungal Disease After Hematopoietic Stem Cell Transplantation
2026.08.28
The 14th Lu Daopei Hematology Forum | Dr. Jiujiang He: Establishing Venetoclax as a Cornerstone and Exploring Standardized Practice—Clinical Applications and Future Perspectives of Venetoclax in AML
2026.08.27
the 14th Lu Daopei Hematology Forum丨Dr. Xiaosu Zhou: Decoding the “Genetic Code” of Atypical APL — Far Greater Complexity and Heterogeneity Than Expected
2026.08.27
Frontiers in Immunology | Germline Genetic Susceptibility Genes May Enable More Precise Donor Selection for Hematopoietic Stem Cell Transplantation — Clinical Insights from a 558-Patient Transplant Cohort
2026.08.27
Posted inIOncology

2026 Pujiang Urological Oncology Academic Conference丨Professor Shudong Zhang: Surgical Treatment and Multidisciplinary Management of UTUC with Inferior Vena Cava Tumor Thrombus — From Precise Imaging Assessment to Robotic Minimally Invasive Thrombectomy and Comprehensive Care

Posted by By Mourabit Halima 2026.09.02
Continue Reading
Posted inIOncology

2026 Pujiang Urological Oncology Academic Conference丨Nan Liu: Precision Strategies for Robot-Assisted Partial Nephrectomy of Completely Endophytic Renal Tumors—from Preoperative 3D Planning to Intraoperative Localization and Nephron-Sparing Decision-Making

Posted by By Peng Longmei 2026.09.02
Continue Reading
Evaluating the Efficacy and Safety of Orelabrutinib-Based Regimens in Diffuse Large B-Cell Lymphoma: A Retrospective Analysis

Evaluating the Efficacy and Safety of Orelabrutinib-Based Regimens in Diffuse Large B-Cell Lymphoma: A Retrospective Analysis

Posted by By Mourabit Halima 2024.03.17
Abstract: Diffuse Large B-Cell Lymphoma (DLBCL) is a heterogeneous malignancy associated with significant morbidity and mortality. Orelabrutinib, a Bruton's tyrosine kinase (BTK) inhibitor, has shown promise as a therapeutic agent…
Read More
Retrospective Analysis of bZIP Region Mutations in CEBPA Double-Mutated Acute Myeloid Leukemia: Implications for Prognosis and Treatment

Retrospective Analysis of bZIP Region Mutations in CEBPA Double-Mutated Acute Myeloid Leukemia: Implications for Prognosis and Treatment

Posted by By Mourabit Halima 2024.03.17
Editor's note: Acute Myeloid Leukemia (AML) characterized by CCAAT-enhancer binding protein alpha (CEBPA) double mutations (CEBPAdm) represents a distinct subtype with varying clinical outcomes. Recent attention has focused on the…
Read More
The Impact of CEBPA Mutations in Hematological Disorders: A Comprehensive Study

The Impact of CEBPA Mutations in Hematological Disorders: A Comprehensive Study

Posted by By Mourabit Halima 2024.03.17
Editor's note: Genetic mutations play a pivotal role in shaping the clinical presentation and prognosis of hematological disorders, with CEBPA mutations emerging as significant contributors to disease pathogenesis. This comprehensive…
Read More
Pediatric-Inspired Therapy Revolutionizes Treatment of Adult Acute Lymphoblastic Leukemia: Insights from a Groundbreaking Chinese Study

Pediatric-Inspired Therapy Revolutionizes Treatment of Adult Acute Lymphoblastic Leukemia: Insights from a Groundbreaking Chinese Study

Posted by By Mourabit Halima 2024.03.15
Introduction: Acute lymphoblastic leukemia (ALL) poses significant challenges in adult patient care, necessitating innovative treatment strategies. Addressing this need, a pioneering study conducted in China investigated the efficacy and safety…
Read More
the Role of the Pinch-Cxcl12-Mbl2 Pathway in Immune and Hematopoietic Homeostasis: Implications for Therapeutic Interventions

the Role of the Pinch-Cxcl12-Mbl2 Pathway in Immune and Hematopoietic Homeostasis: Implications for Therapeutic Interventions

Posted by By Mourabit Halima 2024.03.15
Editor's note: The interplay between bone marrow stromal cells (BMSCs) and immune as well as hematopoietic functions is a complex yet crucial aspect of maintaining overall health. In this study,…
Read More
Intensified Conditioning Regimens for High-Risk ALL Patients Undergoing Allo-HSCT: A Retrospective Analysis

Intensified Conditioning Regimens for High-Risk ALL Patients Undergoing Allo-HSCT: A Retrospective Analysis

Posted by By Mourabit Halima 2024.03.15
Editor's note: The prognosis of high-risk acute lymphoblastic leukemia (ALL) patients undergoing allogeneic hematopoietic stem cell transplantation (allo-HSCT) remains variable, particularly concerning minimal residual disease (MRD) status. Professor Yu Hu…
Read More
Enhancing Early Infection Risk Prediction in Newly Diagnosed Multiple Myeloma: A Nomogram Prognostic Model Approach

Enhancing Early Infection Risk Prediction in Newly Diagnosed Multiple Myeloma: A Nomogram Prognostic Model Approach

Posted by By Mourabit Halima 2024.03.15
Editor's note: In patients with newly diagnosed multiple myeloma (NDMM), infections pose a significant threat to morbidity and mortality, particularly within the initial months post-diagnosis. Immunoparesis, characterized by reduced levels…
Read More
The Role of the Pinch-Cxcl12-Mbl2 Pathway in Immune and Hematopoietic Homeostasis: Implications for Therapeutic Interventions

The Role of the Pinch-Cxcl12-Mbl2 Pathway in Immune and Hematopoietic Homeostasis: Implications for Therapeutic Interventions

Posted by By Mourabit Halima 2024.03.15
Editor's note: The interplay between bone marrow stromal cells (BMSCs) and immune as well as hematopoietic functions is a complex yet crucial aspect of maintaining overall health. In this study,…
Read More
Neutrophil Plasticity in Cancer: A Gateway to Targeted Immunotherapy

Neutrophil Plasticity in Cancer: A Gateway to Targeted Immunotherapy

Posted by By Mourabit Halima 2024.03.15
Editor's note: Neutrophils, once viewed as uniform soldiers of the immune system, are now recognized for their remarkable plasticity within the tumor microenvironment. In a pioneering study led by Melissa…
Read More
Revolutionizing AAV Neutralizing Antibody Detection with CRISPR-Cas9 Technology

Revolutionizing AAV Neutralizing Antibody Detection with CRISPR-Cas9 Technology

Posted by By Mourabit Halima 2024.03.15
Editor's note: Adeno-associated virus (AAV) vector gene therapy holds immense potential for treating genetic disorders. However, the presence of AAV-neutralizing antibodies (NAbs) can hamper its effectiveness. Accurate detection of these…
Read More

Posts pagination

Previous page 1 … 20
Recent Posts
  • 2026 Pujiang Urological Oncology Academic Conference丨Professor Shudong Zhang: Surgical Treatment and Multidisciplinary Management of UTUC with Inferior Vena Cava Tumor Thrombus — From Precise Imaging Assessment to Robotic Minimally Invasive Thrombectomy and Comprehensive Care
  • 2026 Pujiang Urological Oncology Academic Conference丨Nan Liu: Precision Strategies for Robot-Assisted Partial Nephrectomy of Completely Endophytic Renal Tumors—from Preoperative 3D Planning to Intraoperative Localization and Nephron-Sparing Decision-Making
  • The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders
  • The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing
  • The 14th Lu Daopei Hematology Forum | Peihua Lu: Fourteen Years of Staying True to the Mission and Embarking on a New Journey—The Value and Future of an Academic Platform for Hematology
Recent Comments
    Archives
    • September 2026
    • August 2026
    • July 2026
    • June 2026
    • May 2026
    • April 2026
    • March 2026
    • February 2026
    • January 2026
    • December 2025
    • November 2025
    • October 2025
    • September 2025
    • August 2025
    • July 2025
    • June 2025
    • May 2025
    • April 2025
    • March 2025
    • February 2025
    • January 2025
    • December 2024
    • November 2024
    • October 2024
    • September 2024
    • August 2024
    • July 2024
    • June 2024
    • May 2024
    • April 2024
    • March 2024
    • February 2024
    • January 2024
    • December 2023
    • November 2023
    • October 2023
    • August 2023
    Categories
    • Artificial intelligence
    • Hematology Frontier
    • Infectious Disease Frontier
    • International Hepatology
    • IOncology
    • Live broadcasting
    • Uncategorized
    • UroStream
    Post You Might Like
    Posted inIOncology
    2026 Pujiang Urological Oncology Academic Conference丨Professor Shudong Zhang: Surgical Treatment and Multidisciplinary Management of UTUC with Inferior Vena Cava Tumor Thrombus — From Precise Imaging Assessment to Robotic Minimally Invasive Thrombectomy and Comprehensive Care
    Posted by By Mourabit Halima 2026.09.02
    Posted inIOncology
    2026 Pujiang Urological Oncology Academic Conference丨Nan Liu: Precision Strategies for Robot-Assisted Partial Nephrectomy of Completely Endophytic Renal Tumors—from Preoperative 3D Planning to Intraoperative Localization and Nephron-Sparing Decision-Making
    Posted by By Peng Longmei 2026.09.02
    Posted inHematology Frontier
    The 14th Lu Daopei Hematology Forum丨Professor Huili Zhu: Evidence-Based Updates and Precision Prevention and Control — A Clinical Interpretation of the 7th Edition of the Guidelines for Invasive Fungal Disease in Hematologic Disorders
    Posted by By Peter W. PENG 2026.08.28
    Posted inHematology Frontier IOncology
    The 14th Lu Daopei Hematology Forum | Professor Hui Wang: Building the Foundation with Precision Diagnosis, Advancing with Intelligent Empowerment—The Clinical Value and Future Directions of Hematologic Laboratory Testing
    Posted by By Mourabit Halima 2026.08.28
    • LinkedIn
    • Twitter
    • Mail
    Related Media:
    Copyright 2026 — MediaMedic. All rights reserved. Blogun WordPress Theme
    Paris, France
    Scroll to Top

    Welcome to Mediamedic 👋
    It’s nice to meet you.

    Dive into a world of trusted health insights. Subscribe for monthly updates straight to your inbox

    Privacy is part of our care. No spam, just wellness.

    🔒 Privacy policy

    Check your inbox or spam folder to confirm your subscription.

    • Facebook
    • X (Twitter)
    • LinkedIn
    • More Networks
    Share via
    Facebook
    X (Twitter)
    LinkedIn
    Mix
    Email
    Print
    Copy Link
    Copy link
    CopyCopied